Clinical Trial Update: Dose Escalation Trial Of Safety, Pharmacokinetic/Pharmacodynamic And Preliminary Clinical Activity of Briquilimab In Adult Patients With Chronic Spontaneous Urticaria (CSU) [Phase 1, Phase 2]

View source ↗

Summary

This is a dose-escalation study evaluating safety, pharmacokinetics/pharmacodynamics, and preliminary clinical activity of briquilimab in adults with chronic sp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spontaneous Urticaria

Drugs mentioned

• Briquilimab

Snippet

Sponsor: Jasper Therapeutics, Inc. | Conditions: Chronic Spontaneous Urticaria | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING